Portfolio company
CoreMedic
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops transcatheter heart valve repair systems to treat mitral valve regurgitation for patients requiring minimally invasive cardiac interventions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CardioMech AS
This company develops catheter-based artificial chords to repair mitral valves for patients suffering from degenerative mitral regurgitation.
Coramaze
This medical technology company develops a transcatheter valve repair system for treating patients with tricuspid regurgitation and other structural heart conditions.
CardioMech
CardioMech develops a transcatheter-based artificial chordae delivery system for hospitals to treat patients suffering from degenerative mitral regurgitation without open-heart surgery.
HVR Cardio
This company develops transcatheter mitral valve repair devices to treat patients with mitral regurgitation.
CoreValve SA
This company develops trans-catheter aortic valve replacement systems for patients with severe aortic stenosis who are unsuitable for open-heart surgery.
Meacor
Meacor develops a catheter-based medical device for repairing heart valves to treat patients with mitral and tricuspid regurgitation without undergoing open-heart surgery.
Valcare Medical
The company develops transcatheter repair and replacement technologies for heart valves to treat patients with mitral and tricuspid regurgitation.
CroíValve
The company develops a minimally invasive transcatheter valve system to treat tricuspid regurgitation for elderly and frail cardiac patients.
